Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News JOHNSON & JOHNSON JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:JNJ)

Fundamentals Snapshot (NYSE:JNJ)

Bullboard Posts (NYSE:JNJ)

Ophthalmic Lasers Market to Grow at 5.07% CAGR by 2027

The latest research study, "Ophthalmic Lasers Market: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027...
robertsmith02 - August 23, 2022

Point-of-Care Diagnostics Market Size and Share 2021-2026

According to IMARC Group’s latest report, titled “Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth...
edwardebreen15 - August 22, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Richardson35 - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Richardson35 - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Richardson35 - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Richardson35 - May 11, 2022